Profile data is unavailable for this security.
About the company
Coegin Pharma AB, formerly GoldBlue AB (publ) is a Sweden-based biotechnology company. The Company focuses on the development of small molecule therapies aimed at the key enzyme, which is known for its involvement in a variety of inflammatory diseases as well as in cancer. Coegin Pharma AB provides consulting and management services in drug development as well.
- Revenue in SEK (TTM)0.00
- Net income in SEK-35.23m
- Incorporated--
- Employees--
- LocationCoegin Pharma ABc/o Medicon VillageLUND 223 81SwedenSWE
- Phone+46 855925266
- Websitehttps://coeginpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dextech Medical AB | 0.00 | -5.53m | 83.37m | 1.00 | -- | -- | -- | -- | -0.2992 | -0.2992 | 0.00 | -- | -- | -- | -- | -- | -- | -36.80 | -- | -38.28 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 13.26 | -- | -18.38 | -- |
Odi Pharma AB (publ) | 126.32k | -6.75m | 83.71m | -- | -- | 16.69 | -- | 662.68 | -0.4433 | -0.4433 | 0.0083 | 0.3295 | 0.0138 | 0.1962 | 0.4192 | -- | -73.52 | -- | -81.73 | -- | -146.40 | -- | -5,340.67 | -- | 3.64 | -50.07 | 0.00 | -- | -- | -- | -81.81 | -- | -- | -- |
Peptonic Medical AB | 43.60m | -33.60m | 89.31m | -- | -- | 0.9445 | -- | 2.05 | -0.0764 | -0.0764 | 0.0809 | 0.0805 | 0.4539 | 1.38 | 5.24 | -- | -34.97 | -42.70 | -44.65 | -53.76 | 51.99 | 57.62 | -77.06 | -159.81 | 1.84 | -9.86 | 0.068 | -- | 37.89 | 256.60 | 49.98 | -- | -27.03 | -- |
Prolight Diagnostics AB (publ) | 0.00 | -7.95m | 90.04m | -- | -- | 0.2918 | -- | -- | -0.0533 | -0.0533 | 0.00 | 1.09 | 0.00 | -- | -- | -- | -4.96 | -5.03 | -5.05 | -5.18 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -59.41 | -- | -52.37 | -- |
Circio Holding ASA | 9.78m | -423.35m | 90.37m | 21.00 | -- | 34.45 | -- | 9.24 | -2.30 | -2.30 | 0.0531 | 0.0136 | 0.03 | -- | 0.5362 | 476,285.70 | -130.06 | -38.06 | -147.26 | -41.58 | -- | -- | -4,328.13 | -7,234.49 | -- | -284.33 | 0.9611 | -- | -- | 206.46 | -341.86 | -- | 145.16 | -- |
Toleranzia AB | 0.00 | -8.33m | 91.34m | -- | -- | 0.777 | -- | -- | -0.0755 | -0.0755 | 0.00 | 1.07 | 0.00 | -- | -- | -- | -6.54 | -9.51 | -6.80 | -9.95 | -- | -- | -- | -- | -- | -- | 0.0072 | -- | -- | -- | -35.32 | -- | 68.53 | -- |
Ziccum AB | 0.00 | -27.38m | 94.99m | -- | -- | 3.87 | -- | -- | -1.97 | -1.97 | 0.00 | 1.78 | 0.00 | -- | -- | -- | -62.78 | -64.29 | -70.18 | -70.23 | -- | -- | -- | -35,465.64 | -- | -- | 0.0497 | -- | -- | -- | -36.20 | -- | -- | -- |
Chosa Oncology AB | 4.21m | -33.75m | 99.81m | -- | -- | 3.35 | -- | 23.69 | -1.77 | -1.77 | 0.2185 | 0.4748 | 0.1006 | -- | 0.4479 | -- | -80.63 | -51.10 | -133.04 | -59.29 | -- | -- | -801.20 | -683.05 | -- | -- | 0.00 | -- | -58.66 | -- | 38.15 | -- | -- | -- |
2cureX AB | 103.00k | -29.45m | 101.39m | -- | -- | 2.84 | -- | 984.40 | -1.67 | -1.67 | 0.0059 | 2.03 | 0.0019 | -- | 0.0243 | -- | -54.43 | -29.76 | -57.50 | -34.48 | -11,395.15 | -56,037.78 | -28,590.29 | -79,137.78 | -- | -- | 0.00 | -- | -- | 13.88 | -57.21 | -- | 138.57 | -- |
ViroGates A/S | 12.50m | -15.04m | 108.89m | -- | -- | 5.30 | -- | 8.71 | -2.83 | -2.83 | 2.36 | 3.93 | 0.5065 | 0.701 | 4.20 | -- | -60.91 | -45.89 | -72.34 | -50.98 | 75.83 | 28.83 | -120.24 | -272.22 | 10.67 | -1,527.00 | 0.00 | -- | 32.59 | 32.98 | 45.39 | -- | -- | -- |
Coegin Pharma AB | 0.00 | -35.23m | 115.34m | -- | -- | 4.09 | -- | -- | -0.0464 | -0.0464 | 0.00 | 0.03 | 0.00 | -- | -- | -- | -93.21 | -181.00 | -102.33 | -227.45 | -- | -- | -- | -16,235.08 | -- | -30.26 | 0.00 | -- | -- | -- | -29.81 | -- | -- | -- |
Alzinova AB | 0.00 | -15.08m | 132.48m | -- | -- | 0.9525 | -- | -- | -0.5144 | -0.5144 | 0.00 | 3.12 | 0.00 | -- | -- | -- | -14.76 | -9.53 | -15.73 | -9.90 | -- | -- | -- | -- | -- | -- | 0.0078 | -- | -- | -- | -73.30 | -- | 27.04 | -- |
Cereno Scientific AB | 0.00 | -26.82m | 132.49m | -- | -- | 0.3371 | -- | -- | -0.2236 | -0.2236 | 0.00 | 1.43 | 0.00 | -- | -- | -- | -13.92 | -16.92 | -14.79 | -18.62 | -- | -- | -- | -- | -- | -1,974.78 | 0.002 | -- | -- | -- | -70.13 | -- | 39.63 | -- |
New Nordic Healthbrands AB | 490.43m | -3.22m | 135.06m | 37.00 | -- | 1.19 | -- | 0.2754 | -0.5194 | -0.5194 | 79.16 | 18.32 | 1.99 | 1.63 | 4.28 | -- | -1.31 | 9.22 | -2.68 | 17.70 | 64.26 | 68.33 | -0.6562 | 3.95 | 1.04 | -2.23 | 0.284 | 40.92 | -5.31 | 7.18 | -113.25 | -- | 71.01 | -- |
AroCell AB (publ) | 40.27m | -57.16m | 137.76m | -- | -- | 0.659 | -- | 3.42 | -0.2481 | -0.2481 | 0.1748 | 0.9074 | 0.1561 | 5.49 | 6.28 | -- | -22.21 | -30.27 | -23.70 | -32.52 | -1.08 | -14.89 | -142.23 | -348.81 | 5.94 | -- | 0.00 | -- | 208.32 | 136.30 | -17.89 | -- | -- | -- |
Combigene AB | 17.46m | -18.09m | 142.96m | -- | -- | 1.04 | -- | 8.19 | -0.9136 | -0.9136 | 0.882 | 6.94 | 0.1142 | -- | 5.12 | -- | -11.83 | -11.24 | -12.34 | -13.17 | -- | -- | -103.58 | -41.37 | -- | -- | 0.00 | -- | -68.23 | 54.84 | -129.37 | -- | -- | -- |
Data as of Jun 01 2023. Currency figures normalised to Coegin Pharma AB's reporting currency: Swedish Krona SEK